arrow
K

Kazuyuki Nakagome

national center of neurology and psychiatry
H指数:39
被引数:5,306

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

One-month mental health changes and associated factors among users of an online mental health support system during the COVID-19 pandemic

新冠疫情期间在线心理健康支持系统用户一个月内心理健康变化及其相关因素

2026-07-310
OAAI
Gray and White matter microstructural alterations in major depressive disorder: a multi-center diffusion imaging study

重度抑郁症中灰质和白质微观结构的改变:一项多中心扩散成像研究

2026-02-190
OAAI
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trial

佐诺龙在日本成人重度抑郁症患者中的疗效与安全性:一项双盲、随机、安慰剂对照的III期临床试验

2025-11-011
OAAI
VALUABLE INTERACTION WITH COGNITIVE REMEDIATION AND OPTIMAL ANTIPSYCHOTICS FOR RECOVERY IN SCHIZOPHRENIA (VICTORY-S): STUDY PROTOCOL FOR AN INTERVENTIONAL, OPEN-LABEL, RATER- BLINDED, RANDOMIZED COMPARISON OF COMBINED TREATMENT WITH COGNITIVE REMEDIATION AND LURASIDONE OR PALIPERIDONE

认知康复与最佳抗精神病药(利培酮或帕利哌酮)联合治疗精神分裂症康复的宝贵互动(VICTORY-S):一项干预性、开放标签、评估者盲法、随机比较认知康复联合利培酮或帕利哌酮治疗的试验方案

2025-02-120
OA
Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depression
2024-12-160
PRE
Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning
2024-09-050
OAAI
Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone
2024-02-061
OAAI
Association between health anxiety dimensions and preventive behaviors during the COVID-19 pandemic among Japanese healthcare workers

日本医护人员在新型冠状病毒肺炎大流行期间健康焦虑维度与预防行为之间的关联

HELIYON
IF3.6
2023-11-011
OAAI
Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study
2021-11-179
OAAI
Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response

胶质细胞源性神经营养因子的血清水平可作为情绪障碍和锂反应的生物标志物

2021-07-015
PREAI